Search

Your search keyword '"Etablissement français du sang [Poitiers] (EFS)"' showing total 12 results

Search Constraints

Start Over You searched for: Author "Etablissement français du sang [Poitiers] (EFS)" Remove constraint Author: "Etablissement français du sang [Poitiers] (EFS)" Search Limiters Full Text Remove constraint Search Limiters: Full Text
12 results on '"Etablissement français du sang [Poitiers] (EFS)"'

Search Results

1. Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI

2. Is there any impact of HLA-DPB1 disparity in 10/10 HLA-matched unrelated hematopoietic SCT? Results of a French multicentric retrospective study

3. Umbilical cord blood transplants facilitated by the French cord blood banks network. On behalf of the Agency of Biomedicine, Eurocord and the French society of bone marrow transplant and cell therapy (SFGM-TC)

4. Modalités de mobilisation des cellules souches hématopoïétiques autologues et objectifs cellulaires en cellules CD34 + : recommandations de la Société francophone de greffe de mœlle et de thérapie cellulaire (SFGM-TC)

5. Epitope load identifies kidney transplant recipients at risk of allosensitization following minimization of immunosuppression

6. HLA-DRB3/4/5 mismatches are associated with increased risk of acute GVHD in 10/10 matched unrelated donor hematopoietic cell transplantation

7. Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

8. ASSESSING RISK OVER TIME IN PATIENTS WITH SYMPTOMATIC WALDENSTROM MACROGLOBULINEMIA (WM). A STUDY ON 114 PATIENTS (PTS)

9. Impact of donor-specific anti-HLA antibodies on graft failure and survival after reduced intensity conditioning-unrelated cord blood transplantation: a Eurocord, Societe Francophone d'Histocompatibilite et d'Immunogenetique (SFHI) and Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC) analysis

10. Planck 2013 results. XV. CMB power spectra and likelihood

11. Overview of products and scientific results

12. Donor KIR3DL1/3DS1 Gene and Recipient Bw4 KIR Ligand as Prognostic Markers for Outcome in Unrelated Hematopoietic Stem Cell Transplantation

Catalog

Books, media, physical & digital resources